Sarissa Capital Management LP Portfolio Holdings
Sarissa Capital Management LP
- $592 Million
- Q2 2024
Sarissa Capital Management LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $592 Million distributed in 10 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Biogen Inc. with a value of $149M, Innoviva, Inc. with a value of $119M, Ironwood Pharmaceuticals Inc with a value of $107M, Gilead Sciences, Inc. with a value of $75.7M, and Cytokinetics Inc with a value of $60.1M.
Examining the 13F form we can see an increase of $20.9M in the current position value, from $572M to 592M.
Sarissa Capital Management LP is based out at Greenwich, CT
Below you can find more details about Sarissa Capital Management LP portfolio as well as his latest detailed transactions.